Crossmark

RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment

Crossref DOI link: https://doi.org/10.1007/s00428-017-2291-z

Published Online: 2018-01-15

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tack, V.

Ligtenberg, M. J. L.

Siebers, A. G.

Rombout, P. D. M.

Dabir, P. D.

Weren, R. D. A.

van Krieken, J. H. J. M.

Dequeker, E. M. C.
Funding

Funding for this research was provided by:

Amgen Nederland
License Information

Text and Data Mining valid from 2018-01-15
More Information

Article History

Received: 5 October 2017

Revised: 11 December 2017

Accepted: 28 December 2017

First Online: 15 January 2018

Compliance with ethical standards

:

: JHJM van Krieken has received research grants and speaker’s fees from AMGEN, Merck Serrono.

: Not applicable.

: Not applicable